|
|
Volumn 34, Issue 3, 2002, Pages 797-800
|
|
The utility of monoclonal antibody therapy in renal transplantation
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CORTICOSTEROID;
CYCLOSPORIN A;
DACLIZUMAB;
GAMMA INTERFERON;
INTERLEUKIN 2;
INTERLEUKIN 2 RECEPTOR;
INTERLEUKIN 2 RECEPTOR ANTIBODY;
MONOCLONAL ANTIBODY;
OKT 3;
THYMOCYTE ANTIBODY;
TUMOR NECROSIS FACTOR ALPHA;
UNCLASSIFIED DRUG;
ARTICLE;
CLINICAL TRIAL;
DRUG EFFECT;
DRUG EFFICACY;
DRUG RECEPTOR BINDING;
DRUG TOLERABILITY;
DRUG TOLERANCE;
HUMAN;
KIDNEY GRAFT REJECTION;
KIDNEY TRANSPLANTATION;
PRIORITY JOURNAL;
PROPHYLAXIS;
RECEPTOR AFFINITY;
ANTIBODIES, MONOCLONAL;
ANTIGENS, CD;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
KIDNEY TRANSPLANTATION;
MUROMONAB-CD3;
RECEPTORS, INTERLEUKIN-2;
RECOMBINANT FUSION PROTEINS;
TREATMENT OUTCOME;
|
|
EID: 0036262384
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/S0041-1345(01)02914-1 Document Type: Article |
|
Times cited : (10)
|
|
References (37)
|
